As a part of the 2023 Australian Thoracic Aortic Symposium, Dr. Bo Yang presented on his techniques for aortic root enlargement.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
July 13, 2023
In March 2023, the Society for Cardiothoracic Surgery in Great Britain and Ireland brought together surgeons from around the world to discuss topics in CT surgery. These recordings cover the two sessions focused on aortic surgery.
Use the time stamps on each video to direct yourself to each surgeon’s discussion.
June 29, 2023
Transcatheter aortic valve implantation (TAVI) is now a standard procedure for the treatment of symptomatic aortic valve stenosis in many patients.
June 23, 2023
This study analyzed results of aortic valve repair in patients with tricuspid aortic valves and aortic regurgitation caused by prolapse, comparing the results in cases caused by cusp fermentation and myxomatous degeneration.
June 19, 2023
This case report presents the first procedure of a successful implantation of a rapid deployment aortic valve over a mechanical bileaflet valve.
June 5, 2023
Watch Professor Tom Verbelen, from the University Hospital Leuven in Leuven, Belgium, demonstrate a double valve procedure by implanting a Medtronic Avalus™ aortic valve and a Mosaic™ mitral valve.
June 1, 2023
The authors examined the safety of combining aortic root replacement with frozen elephant trunk (FET) total arch replacement. Outcomes were similar between the FET alone and FET with aortic root replacement groups.
Getinge Webinar: Advanced Aortic Root Surgery—A Diversity of Surgical Strategies from Global Experts
May 30, 2023
Check out this recording of a recent webinar CTSNet hosted in collaboration with Getinge, "Advanced Aortic Root Surgery—A Diversity of Surgical Strategies from Global Experts."
May 25, 2023
A study found that patients who underwent a second TAVR procedure were no more likely to experience adverse outcomes than those who have only undergone one TAVR.
